Literature DB >> 19020327

Pulmonary complications of sickle cell disease.

Mark T Gladwin1, Elliott Vichinsky.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 19020327     DOI： 10.1056/NEJMra0804411

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  129 in total

Review 1.  Vasculopathy and pulmonary hypertension in sickle cell disease.

Authors:  Karin P Potoka; Mark T Gladwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-14       Impact factor: 5.464

Review 2.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

3.  Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism.

Authors:  Paul W Buehler; Jin Hyen Baek; Christina Lisk; Ian Connor; Tim Sullivan; Douglas Kominsky; Susan Majka; Kurt R Stenmark; Eva Nozik-Grayck; Joe Bonaventura; David C Irwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-22       Impact factor: 5.464

4.  Pulmonary hypertension and NO in sickle cell.

Authors:  Mark T Gladwin; Robyn J Barst; Oswaldo L Castro; Victor R Gordeuk; Cheryl A Hillery; Gregory J Kato; Daniel B Kim-Shapiro; Roberto Machado; Claudia R Morris; Martin H Steinberg; Elliott P Vichinsky
Journal:  Blood       Date:  2010-08-05       Impact factor: 22.113

5.  Segmentation and quantification of pulmonary artery for noninvasive CT assessment of sickle cell secondary pulmonary hypertension.

Authors:  Marius George Linguraru; John A Pura; Robert L Van Uitert; Nisha Mukherjee; Ronald M Summers; Caterina Minniti; Mark T Gladwin; Gregory Kato; Roberto F Machado; Bradford J Wood
Journal:  Med Phys       Date:  2010-04       Impact factor: 4.071

6.  Vascular risk assessment in patients with sickle cell disease.

Authors:  Claudia R Morris
Journal:  Haematologica       Date:  2011-01       Impact factor: 9.941

7.  Adenosine receptor crossroads in sickle cell disease.

Authors:  Mark T Gladwin
Journal:  Nat Med       Date:  2011-01       Impact factor: 53.440

8.  Adjunctive therapy with inhaled nitric oxide for severe acute chest syndrome in patients with sickle cell disease.

Authors:  Hermann Wrigge; Eduardo L V Costa; Thilo Busch
Journal:  Intensive Care Med       Date:  2015-10-02       Impact factor: 17.440

9.  Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.

Authors:  Robyn J Barst; Kamal K Mubarak; Roberto F Machado; Kenneth I Ataga; Raymond L Benza; Oswaldo Castro; Robert Naeije; Namita Sood; Paul S Swerdlow; Mariana Hildesheim; Mark T Gladwin
Journal:  Br J Haematol       Date:  2010-02-17       Impact factor: 6.998

Review 10.  Pleiotropic effects of intravascular haemolysis on vascular homeostasis.

Authors:  Gregory J Kato; James G Taylor
Journal:  Br J Haematol       Date:  2009-12-01       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.